Issue |
Title |
File |
Vol 87, No 6 (2015) |
Urinary biomarkers for podocyte injury: Significance for evaluating the course and prognosis of chronic glomerulonephritis |
|
Chebotareva N.V., Bobkova I.N., Neprintseva N.V., Kozlovskaya L.V., Malkandueva Z.T.
|
Vol 94, No 6 (2022) |
Urinary biomarkers of kidney injury in patients treated with anti-VEGF drugs |
 (Rus)
|
Grechukhina K.S., Chebotareva N.V., Zhukova L.G., Androsova T.V., Karpov V.V., Krasnova T.N.
|
Vol 87, No 6 (2015) |
Urinary excretion of angiogenesis regulatory factors and renal injury markers in chronic glomerulonephritis: Significance in the assessment of progression |
|
Shvetsov M.Y., Zheng A., Kozlovskaya L.V., Serova A.G., Travkina E.V., Mukhin N.A.
|
Vol 87, No 10 (2015) |
Urinary excretion of markers for podocyte injury in patients with diabetes mellitus |
|
Shchukina A.A., Bobkova I.N., Shestakova M.V., Vikulova O.K., Zuraeva Z.T., Mikhaleva O.V.
|
Vol 84, No 6 (2012) |
URINARY EXCRETION OF PROFIBROTIC AND ANTIFIBROTIC GROWTH FACTORS IN TYPE 1 DIABETIC PATIENTS: THE RELATION WITH DIABETIC NEPHROPATHY |
|
Bondar I.A., Klimontov V.V., Parfentieva E.M., Romanov V.V., Nadeev A.P.
|
Vol 92, No 11 (2020) |
Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria |
 (Rus)
|
Sturov N.V., Popov S.V., Mamporia N.K., Mager A.A.
|
Vol 89, No 8 (2017) |
Uromodulin gene polymorphisms in patients with cast nephropathy in multiple myeloma |
 (Rus)
|
Rekhtina I.G., Mendeleeva L.P., Biderman B.V., Solovyev M.V., Sudarikov A.B.
|
Vol 87, No 4 (2015) |
Ursodeoxycholic acid: A therapeutic niche in an internist’s practice |
|
Drapkina O.M., Bueverova E.L.
|
Vol 86, No 12 (2014) |
Ursodeoxycholic acid-enhanced efficiency and safety of statin therapy in patients with liver, gallbladder, and/or biliary tract diseases: The RACURS study |
|
Martsevich S.I., Kutishenko N.P., Drozdova L.I., Lerman O.V., Nevzorova V.A., Reznik I.I., Shavkuta G.V., Iakhontov D.A.
|
Vol 95, No 6 (2023) |
Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study |
 (Rus)
|
Lebedkina M.S., Fomina D.S., Mutovina Z.Y., Mаrkina U.A., Bogomolov P.O., Chulanov V.P., Lysenko M.A., Alexeeva E.I.
|
Vol 95, No 8 (2023) |
Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease |
 (Rus)
|
Goncharov A.A., Sasunova A.N., Pilipenko V.I., Isakov V.A.
|
Vol 90, No 5 (2018) |
Use of a glycosamine sulfate for patients with osteoarthritis and a comorbidity with high risk of the side effects from NSAIDS |
 (Rus)
|
Naumov A.V., Tkacheva O.N.
|
Vol 82, No 11 (2010) |
Use of a nonselective endothelin receptor antagonist in idiopathic pulmonary hypertension |
|
Arkhipova O.A., Martynyuk T.V., Lazutkina V.K., Ataullakhanova D.M., Stukalova O.V., Danilov N.M., Samoylenko L.E., Chazova I.E., Arkhipova O.A., Martynyuk T.V., Lazutkina V.K., Ataullakhanova D.M., Stukalova O.V., Danilov N.M., Samoilenko L.E., Chazova I.E.
|
Vol 87, No 8 (2015) |
Use of a regional registry of chronic hepatitis patients to optimize antiviral therapy |
|
Tkachenko L.I., Maleev V.V., Sannikova I.V., Titorenko M.V.
|
Vol 82, No 2 (2010) |
USE of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases |
|
Lazebnik L.B., Konoplyannikov A.G., Knyazev O.V., Parfenov A.I., Tsaregorodtseva T.M., Ruchkina I.N., Khomeriki S.G., Rogozina V.A., Konoplyannikova O.A., Lazebnik L.B., Konoplyannikov A.G., Knyazev O.V., Parfenov A.I., Tsaregorodtseva T.M., Ruchkina I.N., Khomeriki S.G., Rogozina V.A., Konoplyannikova O.A.
|
Vol 79, No 10 (2004) |
Use of alpha-adrenoblockers intherapy of benign prostatic hyperplasia in patients with arterial hypertension |
|
Mazo E.В., Shashin M.N.
|
Vol 86, No 5 (2014) |
Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis |
|
Antelava O.A., Khelkovskaia-Sergeeva A.N., Tarasova G.M., Nikishina N.I., Lopatina N.E., Pal'shina S.G., Fedina T.P., Sazhina E.G.
|
Vol 86, No 8 (2014) |
Use of antihistamines in a physician's clinical practice |
|
Luss L.V.
|
Vol 87, No 12 (2015) |
Use of ARTRA MSM FORTE in patients with knee osteoarthritis: Results of a randomized open-label comparative study of the efficacy and tolerability of the drug |
|
Alekseeva L.I., Sharapova E.P., Kashevarova N.G., Taskina E.A., Anikin S.G., Korotkova T.A., Pyanykh S.E.
|
Vol 87, No 8 (2015) |
Use of biological therapy in patients with rheumatoid arthritis in the Republic of Kazakhstan |
|
Nogaeva M.G., Amanzholova A.S.
|
Vol 78, No 8 (2003) |
Use of clonazepam for treatment of patients with paroxysmal atrial fibrillation regarding their psychovegetative status |
|
Nedostup A.V., Solovyeva A.D., Sankova T.A.
|
Vol 89, No 7 (2017) |
Use of crizotinib for refractory ALK-positive lymphomas |
 (Rus)
|
Shelikhova L.N., Fominykh V.V., Abramov D.S., Myakova N.V., Maschan M.A., Maschan A.A.
|
Vol 82, No 11 (2010) |
Use of cyclopheron in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations |
|
Filippova T.P., Vasil'eva L.S., Kochkin A.V., Filippova T.P., Vasilyeva L.S., Kochkin A.V.
|
Vol 85, No 11 (2013) |
Use of darunavir in HIV-infected women during pregnancy |
|
Afonina L.I., Voronin E.E.
|
Vol 86, No 2 (2014) |
Use of fendivia transdermal therapeutic system in Russian patients with malignant neoplasms during palliative care: Pharmacoeconomic aspects |
|
Riazhenov V.V., Abuzarova G.R., Gorokhova S.G., Emchenko I.V., Matveev N.V.
|
Vol 84, No 10 (2012) |
Use of Furamag to prevent inflammatory complications during endoscopic operations in patients with benign prostatic hyperplasia and urolithiasis |
|
Neĭmark A.I., Simashkevich A.V.
|
Vol 96, No 10 (2024): Вопросы эндокринологии |
Use of high-dose matrix formulation of vitamin D for the prevention and treatment of vitamin D deficiency, including in comorbid patients |
 (Rus)
|
Editorial B.
|
Vol 86, No 12 (2014) |
Use of high-frequency chest wall oscillation in an exacerbation of chronic pyo-obstructive bronchitis in adult patients with cystic fibrosis |
|
Amelina E.L., Krasovskiĭ S.A., Usacheva M.V., Krylova N.A.
|
Vol 87, No 10 (2015) |
Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen |
|
Efremova N.V., Bolotskaya L.L., Atarshchikov D.S., Bondarenko O.N., Ilyin A.V., Shestakova M.V.
|
Vol 85, No 11 (2013) |
Use of infusion solution remaxol in the combination treatment of patients with leptospirosis |
|
Lebedev V.V., Zhuravlev A.I., Zotov S.V., Lebedev P.V., Pronin M.G., Podsadniaia A.A., Arbuzova E.K., Svistunov N.V.
|
Vol 82, No 8 (2010) |
Use of inhaled tobramycin in patients with cystic fibrosis |
|
Chermensky A.G., Gembitskaya M.E.
|
Vol 79, No 10 (2004) |
Use of interleukine-2 in a patient with renal cancer and paraneoplastic vasculitis |
|
Demidov L.V., Semenkova E.N., Kharkevich G.Y., Timofeev I.V.
|
Vol 86, No 8 (2014) |
Use of itopride in the symptoms of functional dyspepsia in Russia: Results of a Phase IV prospective open-label multicenter clinical trial |
|
Kas'ianenko V.I., Denisov N.L., Vasil'ev I.V.
|
Vol 89, No 9 (2017) |
Use of loop diuretics in heart failure: Current aspects |
 (Rus)
|
Kurlykina N.V., Seredenina E.M., Orlova Y.A.
|
Vol 85, No 11 (2013) |
Use of maraviroc, the first CCR5 receptor antagonist, in HIV treatment regimens |
|
Kravchenko A.V.
|
Vol 82, No 12 (2010) |
Use of melatonin in combined treatment for inflammatory bowel diseases |
|
Rakhimova O.Y., Rakhimova O.Y.
|
Vol 86, No 4 (2014) |
Use of meldonium in the combination treatment of patients with heart failure in the early post-infarction period |
|
Statsenko M.E., Shilina N.N., Turkina S.V.
|
Vol 88, No 2 (2016) |
Use of mesenchymal stem cells in the combination therapy of ulcerative colitis |
 (Rus)
|
Knyazev O.V., Parfenov A.I., Konoplyannikov A.G., Boldyreva O.N.
|
Vol 78, No 5 (2003) |
Use of monoclonal antibodies to tumor necrosis factor (the drug remicade) in rheumatoid arthritis: pilot results |
|
Lukina G.V., Sigidin Y.A., Chichasova N.V., Balabanova R.M., Belenky A.G., Imametdinova G.R., Barskova V.G., Bochkova A.G., Gukasyan D.A., Egorova О.N., Karateev D.E., Kolosova I.R., Loginova E.Y., Pudovkina E.Y., Stanislav M.L., Taukumova L.A., Fedina T.P., Nasonov E.L.
|
Vol 84, No 12 (2012) |
Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study |
|
Martyniuk T.V., Konosova I.D., Chazova I.E.
|
Vol 78, No 3 (2003) |
Use of nebivolol in patients with mild and moderate hypertensive disease |
|
Zhigunova L.V., Lakhova Y.L., Yurenev A.P.
|
Vol 86, No 11 (2014) |
Use of nonsteroidal anti-inflammatory drugs in case of ankylosing spondylitis: Long and persistently! |
|
Karateev A.E., Érdes S.F.
|
Vol 89, No 1 (2017) |
Use of pharmacogenetic testing to prevent adverse drug reactions during statin therapy |
 (Rus)
|
Rumyantsev N.A., Kukes V.G., Kazakov R.E., Rumyantsev A.A., Sychev D.A.
|
Vol 88, No 12 (2016) |
Use of probiotics and probiotic-based immunomodulators as adjuvant therapy for Helicobacter pylori eradication |
 (Rus)
|
Konorev M.R., Andronova T.M., Matveenko M.E.
|
Vol 84, No 10 (2012) |
Use of remaxol in the combination therapy of post-withdrawal disorders in alcoholic patients with comorbid liver damage |
|
Bokhan N.A., Abolonin A.F., Ankudinova I.É., Kurgak D.I., Mandel' A.I.
|
Vol 88, No 11 (2016) |
Use of succinate-containing agents in the treatment of infectious diseases |
 (Rus)
|
Tikhonova E.O., Lyapina E.P., Shul’dyakov A.A., Satarova S.A.
|
Vol 87, No 6 (2015) |
Use of the Charlson comorbidity index and the Barthel disability index in the integrated assessment of the sociomedical status of patients receiving continuous renal replacement therapy with hemodialysis |
|
Vishnevsky K.A., Zemchenkov A.Y., Korosteleva N.Y., Smirnov A.V.
|
Vol 84, No 12 (2012) |
Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy |
|
Konorev M.R.
|
Vol 84, No 10 (2012) |
Use of the mucoregulator ascoril for respiratory diseases |
|
Shmeleva N.M.
|
Vol 82, No 12 (2010) |
Use of various nutritional support regimens in patients with transplanted hematopoietic stem cells |
|
Kucher M.A., Goloshchapov O.V., Ganapiev A.A., Afanas'ev B.V., Kucher M.A., Goloshchapov O.V., Ganapiyev A.A., Afanasyev B.V.
|
4051 - 4100 of 4186 Items |
<< < 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 > >> |